glp 1 conversion chart Injectable GLP-1 Receptor Agonists Customized Compounded GLP-1 Weight Loss
Description
The administration of unacylated, acylated, and PEGylated versions of this co-agonist dose-dependently reduced body weight, food intake, and fat mass and improved glycemic control and insulin sensitivity in rodent models of obesity and diabetes with greater efficacy than equimolar doses of GLP-1R agonist comparators exendin-4 and liraglutide [77]
Peripheral administration of lactate produces antidepressant-like effects
Besides, they can be used alone or alongside metformin, SGLT2 inhibitors, or other glucoselowering medications for enhanced effectiveness
Adv Clin Exp Med (2020) 29:6618
